Authors:
Oury, TD
Thakker, K
Menache, M
Chang, LY
Crapo, JD
Day, BJ
Citation: Td. Oury et al., Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin, AM J RESP C, 25(2), 2001, pp. 164-169
Citation: Lw. Velsor et al., Antioxidant imbalance in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice, AM J P-LUNG, 281(1), 2001, pp. L31-L38
Authors:
Mackensen, GB
Patel, M
Sheng, HX
Calvi, CL
Batinic-Haberle, I
Day, BJ
Liang, LP
Fridovich, I
Crapo, JD
Pearlstein, RD
Warner, DS
Citation: Gb. Mackensen et al., Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant, J NEUROSC, 21(13), 2001, pp. 4582-4592
Citation: W. Lewis et al., Mitochondrial DNA depletion, oxidative stress, and mutation: Mechanisms ofdysfunction from nucleoside reverse transcriptase inhibitors, LAB INV, 81(6), 2001, pp. 777-790
Citation: J. Milano et Bj. Day, A catalytic antioxidant metalloporphyrin blocks hydrogen peroxide-induced mitochondrial DNA damage, NUCL ACID R, 28(4), 2000, pp. 968-973